The UCL Institute of Cardiovascular Science brings together basic and clinical scientists from UCL and expert clinicians from UCL partner hospitals to provide:

  • Innovative research for the prevention and treatment of diseases of the heart and circulation
  • World-class teaching and training in the Cardiovascular Sciences¬†
  • Forward-thinking policy development for effective Cardiovascular disease management

We have about 140 members of staff and 40 research students who are based in different research centres across the Bloomsbury campus and in UCL partner hospitals.

Our research is broad, spanning discovery-based laboratory science, clinical translation and experimental medicine, as well as healthcare evaluation, implementation and policy. Much of the work is interdisciplinary, integrating with UCL Engineering, Nanotechnology, Chemistry, Behavioural Science, and the UCL Genetics Institute. We have a flourishing link with leading cardiovascular scientists and clinicians at Yale University through the Yale UCL Collaborative.

The Heart Hospital QMUL Yale Cardiometabolic domain





Find out about the work that takes place in the research centres of Great Ormond Street Hospital, Hatter Cardiovascular Institute, The Heart Hospital, The Rayne Institute, UCL Institute of Child Health, UCL Institute of Ophthalmology.

ICS researchers collaborate extensively with colleagues at the William Harvey Research Institute at Barts and The London School of Medicine and Dentistry.

Yale and UCL have entered into a unique partnership called the Yale UCL Collaborative. UCL PhD students are able to apply for the Yale exchange programme. This has been designed to provide students with the opportunity to study at Yale for a defined period of research.

The domain encompasses research into obesity, diabetes, cardiovascular risk, metabolic syndrome/insulin resistance, cardiovascular physiology and disease, vascular cell biology, microangiopathies, as well as related clinical trials.